Search Results

There are 20489 results for: content related to: Food Effect

  1. Rate- and Extent-Limiting Factors of Oral Drug Absorption: Theory and Applications

    Journal of Pharmaceutical Sciences

    Volume 104, Issue 9, September 2015, Pages: 2777–2788, Kiyohiko Sugano and Katsuhide Terada

    Version of Record online : 24 FEB 2015, DOI: 10.1002/jps.24391

  2. You have free access to this content
    Evaluation of the Use of Göttingen Minipigs to Predict Food Effects on the Oral Absorption of Drugs in Humans

    Journal of Pharmaceutical Sciences

    Volume 104, Issue 1, January 2015, Pages: 135–143, Martin Lau Christiansen, Anette Müllertz, Mats Garmer, Jakob Kristensen, Jette Jacobsen, Bertil Abrahamsson and Rene Holm

    Version of Record online : 21 NOV 2014, DOI: 10.1002/jps.24270

  3. Oral Anticancer Drugs: Back to Square One

    Clinical Pharmacology & Therapeutics

    Volume 94, Issue 4, October 2013, Pages: 441–442, W Weitschies

    Version of Record online : 24 MAY 2013, DOI: 10.1038/clpt.2013.112

  4. Clinical trial simulation to evaluate population pharmacokinetics and food effect: Capturing abiraterone and nilotinib exposures

    The Journal of Clinical Pharmacology

    Volume 55, Issue 5, May 2015, Pages: 556–562, Claire H. Li, Eric A. Sherer, Lionel D. Lewis and Robert R. Bies

    Version of Record online : 4 FEB 2015, DOI: 10.1002/jcph.449

  5. Understanding pharmacokinetic food effects using molecular dynamics simulation coupled with physiologically based pharmacokinetic modeling

    Biopharmaceutics & Drug Disposition

    Volume 33, Issue 9, December 2012, Pages: 510–521, David C. Turner, Fuchang Yin, James T. Kindt and Hailing Zhang

    Version of Record online : 7 NOV 2012, DOI: 10.1002/bdd.1818

  6. A quantitative approach to probe the dependence and correlation of food-effect with aqueous solubility, dose/solubility ratio, and partition coefficient (Log P) for orally active drugs administered as immediate-release formulations

    Drug Development Research

    Volume 65, Issue 2, June 2005, Pages: 55–75, Brahma N. Singh

    Version of Record online : 14 OCT 2005, DOI: 10.1002/ddr.20008

  7. Effects of Food on Drug Absorption

    Oral Bioavailability: Basic Principles, Advanced Concepts, and Applications

    Venugopal P. Marasanapalle, Xiaoling Li, Bhaskara R. Jasti, Pages: 221–231, 2011

    Published Online : 5 JUL 2011, DOI: 10.1002/9781118067598.ch14

  8. Development and validation of a preclinical food effect model

    Journal of Pharmaceutical Sciences

    Volume 96, Issue 2, February 2007, Pages: 459–472, Kimberley A. Lentz, Megan Quitko, Daniel G. Morgan, James E. Grace Jr., Carol Gleason and Punit H. Marathe

    Version of Record online : 30 OCT 2006, DOI: 10.1002/jps.20767

  9. Utilizing Physiologically Based Pharmacokinetic Modeling to Inform Formulation and Clinical Development for a Compound with pH-Dependent Solubility

    Journal of Pharmaceutical Sciences

    Volume 104, Issue 4, April 2015, Pages: 1522–1532, John Chung, Fernando Alvarez-Nunez, Vincent Chow, Dominick Daurio, John Davis, Michael Dodds, Maurice Emery, Kevin Litwiler, Anne Paccaly, Joanna Peng, Brooke Rock, Larry Wienkers, Charles Yang, Zhigang Yu and Jan Wahlstrom

    Version of Record online : 15 JAN 2015, DOI: 10.1002/jps.24339

  10. Playing Russian Roulette With Tyrosine Kinase Inhibitors

    Clinical Pharmacology & Therapeutics

    Volume 93, Issue 3, March 2013, Pages: 242–244, R Z Szmulewitz and M J Ratain

    Version of Record online : 18 DEC 2012, DOI: 10.1038/clpt.2012.245

  11. A formulation strategy for gamma secretase inhibitor ELND006, a BCS class II compound: Development of a nanosuspension formulation with improved oral bioavailability and reduced food effects in dogs

    Journal of Pharmaceutical Sciences

    Volume 101, Issue 4, April 2012, Pages: 1462–1474, Kevin Quinn, Rampurna Prasad Gullapalli, Elaine Merisko-liversidge, Erich Goldbach, Angelina Wong, Gary G. Liversidge, Wherly Hoffman, John-michael Sauer, John Bullock and George Tonn

    Version of Record online : 28 DEC 2011, DOI: 10.1002/jps.23034

  12. Suitability of a Minipig Model in Assessing Clinical Bioperformance of Matrix and Multiparticulate Extended-Release Formulations for a BCS Class III Drug Development Candidate

    Journal of Pharmaceutical Sciences

    Volume 103, Issue 2, February 2014, Pages: 636–642, Filippos Kesisoglou, Iris Huizhi Xie, Kimberly Manser, Yunhui Wu, Ian Hardy and Shaun Fitzpatrick

    Version of Record online : 30 DEC 2013, DOI: 10.1002/jps.23837

  13. Influence of a Fat-Rich Meal on Bioavailability of Extended-Release and Immediate-Release Propiverine

    The Journal of Clinical Pharmacology

    Volume 52, Issue 5, May 2012, Pages: 681–690, Dr Werner Siegmund, Dr Joachim Siegert, Dr Klaus Richter, Dr Frieder Schnabel, Dr Cornelia Feustel and Dr Wilhelm Kirch

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270011401260

  14. You have free access to this content

    Biopharmaceutics Modeling and Simulations: Theory, Practice, Methods, and Applications

    Kiyohiko Sugano, Pages: 477–483, 2012

    Published Online : 8 AUG 2012, DOI: 10.1002/9781118354339.index

  15. Investigation of some factors contributing to negative food effects

    Biopharmaceutics & Drug Disposition

    Volume 30, Issue 2, March 2009, Pages: 71–80, Venugopal P. Marasanapalle, John R. Crison, Jingwen Ma, Xiaoling Li and Bhaskara R. Jasti

    Version of Record online : 19 FEB 2009, DOI: 10.1002/bdd.647

  16. On the assessment of effects of food on the pharmacokinetics of drugs in early development

    Biopharmaceutics & Drug Disposition

    Volume 23, Issue 4, May 2002, Pages: 165–171, Zhihong Li, Nimish N. Vachharajani and Rajesh Krishna

    Version of Record online : 9 MAY 2002, DOI: 10.1002/bdd.309

  17. You have free access to this content
    Dietary Fat Modulates the Testosterone Pharmacokinetics of a New Self-Emulsifying Formulation of Oral Testosterone Undecanoate in Hypogonadal Men

    Journal of Andrology

    Volume 33, Issue 6, November-December 2012, Pages: 1282–1290, Anthony Yin, Eman Alfadhli, Michelle Htun, Robert Dudley, Sandra Faulkner, Laura Hull, Andrew Leung, Rachelle Bross, James Longstreth, Ronald Swerdloff and Christina Wang

    Version of Record online : 2 JAN 2013, DOI: 10.2164/jandrol.112.017020

  18. Bioavailability and Bioequivalence

    Standard Article

    Encyclopedia of Drug Metabolism and Interactions

    Benny M. Amore

    Published Online : 31 JAN 2012, DOI: 10.1002/9780470921920.edm030

  19. A Phase 1 Study to Evaluate the Bioavailability and Food Effect of 2 Solid-Dispersion Formulations of the TRPV1 Antagonist ABT-102, Relative to the Oral Solution Formulation, in Healthy Human Volunteers

    Clinical Pharmacology in Drug Development

    Volume 1, Issue 1, January 2012, Pages: 24–31, Dr Ahmed A. Othman, Howard Cheskin, Charles Locke, Wolfram Nothaft and Sandeep Dutta

    Version of Record online : 10 JAN 2013, DOI: 10.1177/2160763X11430860

  20. A Single-Dose Bioequivalence and Food Effect Study With Aprepitant and Fosaprepitant Dimeglumine in Healthy Young Adult Subjects

    Clinical Pharmacology in Drug Development

    Volume 1, Issue 3, July 2012, Pages: 93–101, Craig R. Shadle, M. Gail Murphy, Yang Liu, Maureen Ho, Daniel Tatosian, Susie (Xiujiang) Li and Robert A. Blum

    Version of Record online : 10 JAN 2013, DOI: 10.1177/2160763X12447304